¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"primary response"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
middle latency response
Áß°£Àẹ¹ÝÀÀ
myotatic response
±ÙÀ°½ÅÀü¹ÝÀÀ
memory immune response
¸é¿ª±â¾ï¹ÝÀÀ
microphonic response
¸¶ÀÌÅ©·ÎÆù¹ÝÀÀ
placebo response
¼ÓÀÓ¾à¹ÝÀÀ, Çö󼼺¸¹ÝÀÀ
pyramidal tract response
ÇǶó¹Ìµå·Î¹ÝÀÀ, Ãßü·Î¹ÝÀÀ
recruiting response
µ¿¿ø¹ÝÀÀ
response
¹ÝÀÀ
response bias
¹ÝÀÀÄ¡¿ìħ
response curve
¹ÝÀÀ°î¼±
response decline
¹ÝÀÀ°¨¼Ò
response frequency
¹ÝÀÀÁ֯ļö
response modulation
¹ÝÀÀÁ¶Á¤
response prevention
¹ÝÀÀ¿¹¹æ
response rate
¹ÝÀÀ·ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
response frequency
¹ÝÀÀÁ֯ļö
galvanic skin response
Àü±âÇǺιÝÀÀ
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
heat shock response
¿Ãæ°Ý¹ÝÀÀ
idiosyncratic drug response
ƯÀ̾๰¹ÝÀÀ
immune response
¸é¿ª¹ÝÀÀ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦
inert response
ºÒȰ¼º¹ÝÀÀ
inflammatory response
¿°Áõ¹ÝÀÀ
inspiratory triggering response time
µé¼ûÀ¯¹ß¹ÝÀÀ½Ã°£
inverse response
¿ª¹ÝÀÀ
lytic response
¿ëÇØ¹ÝÀÀ
memory immune response
¸é¿ª±â¾ï¹ÝÀÀ
microphonic response
¸¶ÀÌÅ©·ÎÆù¹ÝÀÀ
myotactic response
±ÙÀ°½ÅÀü¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
immunological response
¸é¿ªÇÐÀû¹ÝÀÀ
inert response
ºÒȰ¼º ¹ÝÀÀ
inspiratory triggering response time
Èí±âÀ¯¹ß¹ÝÀÀ½Ã°£.
placebo response
Çö󼼺¸¹ÝÀÀ, À§¾à¹ÝÀÀ, ¼ÓÀÓ¾à¹ÝÀÀ.
placebo response
Çö󼼺¸¹ÝÀÀ, À§<°¡>¾à¹ÝÀÀ.
positive placebo response
Çö󼼺¸Ä¡·á È¿°ú.
pressure response
À½¾Ð¹ÝÀÀ(ëåäâÚãëë).
radiation response
¹æ»ç¼±¹ÝÀÀ
recruiting response
µ¿¿ø¹ÝÀÀ(ÔÑê¬Úãëë).
Ghon s primary complex
°ï¿ø¹ßÁõÈıº.
amyloidosis primary
¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
immunodeficiency syndrome, primary
ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
infection, primary
ÀÏÂ÷°¨¿°
interaction, primary
ÀÏÂ÷»óÈ£ÀÛ¿ë
pneumonia, primary atypical
¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
bulbocavernous evoked-response test
±¸Çظéü À¯¹ß¹ÝÀÀ°Ë»ç
cellular response
¼¼Æ÷¼º¹ÝÀÀ
chemotactic response
ÈÇÐÁÖ¼º¹ÝÀÀ
complete response
¿ÏÀü°üÇØ, -¹ÝÀÀ
concentration-response curve
³óµµ¹ÝÀÀ°î¼±
conditioned avoidance response
Á¶°ÇȸÇǹÝÀÀ(ðÉËìüÞùùÚãëë).
conditioned emotional response
Á¶°ÇȰ¨Á¤¹ÝÀÀ(ðÉËìûùÊïï×Úãëë)
conditioned fear response
Á¶°ÇȰøÆ÷¹ÝÀÀ(ðÉËìûùÍðø×Úãëë)
conditioned response
Á¶°ÇȹÝÀÀ(ðÉËìûùÚãëë)
consummatory response
¼ºÃë¹ÝÀÀ(à÷ö¦Úãëë)
delayed response
Áö¿¬¹ÝÀÀ(òÀæÅÚãëë).
dose response curve
¹æ»ç [¾à¸®,º´¸®,»ýÈ,ÇÙÀÇ]¿ë·®¹ÝÀÀ°î¼±(éÄåÖÚãëëÍØàÊ).
dose response curve
¹æ»ç ¾à¸®,º´¸®,»ýÈ,ÇÙÀǿ뷮´ëÀÀ°î¼±(éÄåÖÓßëëÍØàÊ).
dose response curve/relationship
¿ë·®-¹ÝÀÀ°î¼±/°ü°è.
dose response relationship
¹æ»ç ¾à¸®,»ý¸®,»ýÈ,ÇÙÀǿ뷮¹ÝÀÀ°ü°è (¡Î¼Ìõ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½